This inventor holds 1 USPTO granted patent. Top assignee: Ltb4 Sweden Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations of Louis Flamand
Introduction
Louis Flamand is a notable inventor based in Sainte-Foy, Canada. He has made significant contributions to the field of immunology through his innovative work on vaccine adjuvants. His research focuses on enhancing the immune response to vaccines, which is crucial for improving public health outcomes.
Latest Patents
Flamand holds a patent related to a vaccine adjuvant that enhances the immune response of individuals receiving vaccines. This invention comprises an immune-enhancing effective amount of an LTB4 agent in association with a pharmaceutically effective vaccine carrier. His patent represents a significant advancement in vaccine technology, potentially leading to more effective immunizations.
Career Highlights
Throughout his career, Louis Flamand has been associated with LTB4 Sweden AB, where he has furthered his research and development efforts. His work has been instrumental in bridging the gap between basic research and practical applications in vaccine development.
Collaborations
Flamand has collaborated with notable colleagues such as Jean Gosselin and Pierre Borgeat. These partnerships have enriched his research and contributed to the advancement of innovative solutions in the field of immunology.
Conclusion
Louis Flamand's contributions to vaccine adjuvant technology highlight his role as a key innovator in the field. His work not only enhances vaccine efficacy but also underscores the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile